Oxford Asset Management »

Evommune shares owned by Oxford Asset Management

Quarter-by-quarter ownership of Evommune (EVMN) shares owned by Oxford Asset Management from 13F filings

Historical chart of Oxford Asset Management investment in Evommune

Tip: Access up to 7 years of quarterly data

All positions including Evommune held by Oxford Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evommune by Oxford Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $335k 20k 17.12

More positions owned by Oxford Asset Management

Spdr Series Trust State Street Spd (XBI)
Netflix (NFLX)
Marvell Technology (MRVL)
Boeing Company (BA)
Micron Technology (MU)
Nordson Corporation (NDSN)
Jamf Hldg Corp
Denny's Corporation
UnitedHealth (UNH)
Sherwin-Williams Company (SHW)
Kroger (KR)
EOG Resources (EOG)
Cidara Therapeutics Com New (CDTX)
Citigroup Com New (C)
Maximus (MMS)

View all positions for Oxford Asset Management

Top funds holding Evommune

EQT Fund Management S.a r.l.
RA Capital Management
Pivotal bioVenture Partners Investment Advisor
Nan Fung Group Holdings
Rtw Investments
Marshall Wace
Eventide Asset Management
Sectoral Asset Management
Verition Fund Management
Standard Life Aberdeen
Velan Capital Investment Management
Vanguard Group
Octagon Capital Advisors
American Century Companies
Federated Investors

View all funds holding Evommune